tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Income Statement

Compare
0 Followers

Bafna Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), Bafna Pharmaceuticals Limited's total revenue was ₹346.24M, an increase of 4.02% from the same quarter last year. In Q1, Bafna Pharmaceuticals Limited's net income was ₹33.89M. See Bafna Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 1.46B₹ 1.52B₹ 1.15B₹ 851.40M₹ 712.18M
Gross Profit
₹ 168.77M₹ 452.15M₹ 387.56M₹ 338.60M₹ 257.62M
Operating Expenses
₹ 105.89M₹ 214.49M₹ 71.63M₹ 272.51M₹ 196.24M
Depreciation and Amortization
₹ 48.90M₹ 49.95M₹ 53.34M₹ 54.93M₹ 44.78M
EBITDA
₹ 117.73M₹ 146.34M₹ 189.88M₹ 112.34M₹ 103.94M
Operating Income
₹ 62.87M₹ 237.66M₹ 103.92M₹ 64.98M₹ 58.55M
Other Income/Expenses
₹ -21.35M₹ -164.18M₹ 12.24M₹ -12.82M₹ -279.00K
Pretax Income
₹ 41.52M₹ 73.48M₹ 116.16M₹ 52.16M₹ 58.27M
Net Income
₹ 41.52M₹ 73.48M₹ 113.38M₹ 52.16M₹ 58.27M
Per Share Metrics
Basic EPS
₹ 1.76₹ 3.11₹ 4.79₹ 2.21₹ 2.46
Diluted EPS
₹ 1.76₹ 3.11₹ 4.79₹ 2.21₹ 2.46
Weighted Average Shares Outstanding
23.69M 23.63M 23.66M 23.66M 23.69M
Weighted Average Shares Outstanding (Diluted)
23.69M 23.66M 23.66M 23.66M 23.69M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History